Patents by Inventor Jiahu Wu

Jiahu Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystal form as ASK1 inhibitor and preparation method and application thereof
    Patent number: 11814382
    Abstract: Provided are crystal forms A, B, C and D of a compound of formula (I), and application of the crystal forms in the preparation of drugs for treating ASK1-related diseases.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: November 14, 2023
    Assignee: FUJIAN AKEYLINK BIOTECHNOLOGY CO., LTD.
    Inventors: Shengbin Zhang, Ning Li, Tao Yu, Yusheng Fu, Jiahu Wu, Chengde Wu
  • BRD4 INHIBITOR COMPOUND IN SOLID FORM AND PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20220185820
    Abstract: Disclosed are a solid form and a crystal form of a compound represented by formula (I) used as a BRD4 inhibitor, a preparation method therefor, and an application thereof in the preparation of a medicine for treating BRD4-related diseases.
    Type: Application
    Filed: March 23, 2020
    Publication date: June 16, 2022
    Inventors: Chunli SHEN, Yong LIU, Huanyu BIAN, Chengde WU, Jiahu WU
  • CRYSTAL OF DIARYLTHIOHYDANTOIN COMPOUND
    Publication number: 20220009925
    Abstract: The present application belongs to the field of medicine, and in particular relates to a crystal of a diarylthiohydantoin compound having a structure of the following formula (I), a preparation method therefor, and use thereof in the preparation of medicaments for treating related diseases which are androgen-mediated.
    Type: Application
    Filed: January 22, 2020
    Publication date: January 13, 2022
    Inventors: Chunli SHEN, Shenglin CHEN, Ting Wang, Fei Liu, Xin TIAN, Yuing GUO, Lin ZHANG, Jiahu WU
  • Crystal form as ASK1 inhibitor and preparation method and application thereof
    Publication number: 20210269441
    Abstract: Provided are crystal forms A, B, C and D of a compound of formula (I), and application of the crystal forms in the preparation of drugs for treating ASK1-related diseases.
    Type: Application
    Filed: July 19, 2019
    Publication date: September 2, 2021
    Inventors: Shengbin ZHANG, Ning LI, Tao YU, Yusheng FU, Jiahu WU, Chengde WU
  • Sustained release suspension containing dezocine analogue ester and preparation method therefor
    Patent number: 10744109
    Abstract: Disclosed are a sustained release suspension containing dezocine analogue ester and a preparation method therefor. According to the present invention, an injectable oily auxiliary material which may pharmaceutically serve as a sustained-release depot and an excipient are selected, and micronization technology is used jointly with high pressure homogenization technology and an anti-solvent technique to prepare an injectable long-acting suspension. The main components of the suspension are a compound represented by formula (I), the injectable oil, and the like.
    Type: Grant
    Filed: August 7, 2018
    Date of Patent: August 18, 2020
    Assignee: SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
    Inventors: Yang Zhang, Bing Deng, Jiahu Wu, Wentao Wu, Zhixiang Li
  • SUSTAINED RELEASE SUSPENSION CONTAINING DEZOCINE ANALOGUE ESTER AND PREPARATION METHOD THEREFOR
    Publication number: 20200188342
    Abstract: Disclosed are a sustained release suspension containing dezocine analogue ester and a preparation method therefor. According to the present invention, an injectable oily auxiliary material which may pharmaceutically serve as a sustained-release depot and an excipient are selected, and micronization technology is used jointly with high pressure homogenization technology and an anti-solvent technique to prepare an injectable long-acting suspension. The main components of the suspension are a compound represented by formula (I), the injectable oil, and the like.
    Type: Application
    Filed: August 7, 2018
    Publication date: June 18, 2020
    Inventors: Yang ZHANG, Bing DENG, Jiahu WU, Wentao WU, Zhixiang LI
  • Pyrido[1,2-A]pyrimidone analog, crystal form thereof, intermediate thereof and preparation method therefor
    Patent number: 10479789
    Abstract: Disclosed in the present invention are a crystalline Form of pyrido[1,2-a]pyrimidone analog, a preparation method therefor and an intermediate thereof.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: November 19, 2019
    Assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Inventors: Tao Yu, Ning Li, Lingwei Kong, Peipei Jiang, Yong Wang, Zhemin Rong, Changjun Wang, Feng Guo, Zongbin Li, Zheng Wang, Jiahu Wu, Chengde Wu
  • PYRIDO[1,2-A]PYRIMIDONE ANALOG, CRYSTAL FORM THEREOF, INTERMEDIATE THEREOF AND PREPARATION METHOD THEREFOR
    Publication number: 20180319799
    Abstract: Disclosed in the present invention are a crystalline Form of pyrido[1,2-a]pyrimidone analog, a preparation method therefor and an intermediate thereof,
    Type: Application
    Filed: December 16, 2016
    Publication date: November 8, 2018
    Inventors: Tao Yu, Ning Li, Lingwei Kong, Peipei Jiang, Yong Wang, Zhemin Rong, Changjun Wang, Feng Guo, Zongbin Li, Zheng Wang, Jiahu Wu, Chengde Wu